Applied DNA Sciences, Inc. (APDN) Chart Is Flashing Mixed Signals

Applied DNA Sciences, Inc. (NASDAQ:APDN) went up by 6.15% from its latest closing price when compared to the 1-year high value of $19.69 and move down -75.49%, while APDN stocks collected +43.66% of gains with the last five trading sessions. Press Release reported on 07/17/20 that Thinking about buying stock in Applied DNA Sciences, Microvision, Virgin Galactic, Blink Charging, or Novavax?

>> Stay Up To Date On The Best Stocks Under $5 + Market Moving Updates 100% Free. Join Today! <<

Applied DNA Sciences, Inc. (NASDAQ:APDN) Worth an Investment?

Applied DNA Sciences, Inc. (NASDAQ: APDN) The 36 Months beta value for APDN stocks is at 1.03, while 2 of the analysts out of 2 who provided ratings for Applied DNA Sciences, Inc. stocks as a “buy” while 0 as overweight, 0 rated it as hold and 0 as sell. The average price we get from analysts is $21.50 which is -$11.22 below current price. APDN currently has a short float of 9.66% and public float of 3.95M with average trading volume of 2.13M shares.

APDN Market Performance

APDN stocks went up by 43.66% for the week, with the monthly jump of 51.83% and a quarterly performance of 76.42%, while its annual performance rate touched -7.12%. The simple moving average for the period of the last 20 days is 32.80% for APDN stocks with the simple moving average of 81.67% for the last 200 days.

Analysts’ Opinion on Applied DNA Sciences, Inc. (NASDAQ:APDN)

Many brokerage firms have already submitted their reports for APDN stocks, with H.C. Wainwright repeating the rating for APDN shares by setting it to “Buy”. The predicted price for APDN socks in the upcoming period according to H.C. Wainwright is $22 based on the research report published on July 20, 2020.

H.C. Wainwright, on the other hand, stated in their research note that they expect to see APDN stock at the price of $18. The rating they have provided for APDN stocks is “Buy” according to the report published on July 2, 2020.

Maxim Group gave “Buy” rating to APDN stocks, setting the target price at $6 in the report published on November 14, 2016.

APDN Stocks 25.22% Far from 50 Day Moving Average

After a stumble in the market that brought APDN to its low price for the period of the last 52 weeks, Applied DNA Sciences, Inc. was unable to take a rebound, for now settling with -43.02% of loss for the given period.

The stock volatility was left at 12.30%, however, within the period of a single month, the volatility rate increased by 21.36%, while the shares surge at the distance of +41.67% for the moving average in the last 20 days. In oppose to the moving average for the last 50 days, trading by +18.35% upper at the present time.

In the course of the last 5 trading sessions, APDN went up by +43.66%, which changed the moving average for the period of 200 days to the total of +22.33% of gains for the stock in comparison to the 20-day moving average settled at $8.61. In addition, Applied DNA Sciences, Inc. saw 167.78% in overturn over the period of a single year with a tendency to cut further gains.

APDN Stock Insider Trading

Reports are indicating that there were more than several insider trading activities at Applied DNA Sciences, Inc. (APDN), starting from Montgomery William W, who bought 110,000 shares at the price of $5.25 back on Jun 26. After this action, Rushing now owns 245,000 shares of Applied DNA Sciences, Inc., valued at $577,500 with the latest closing price.

Montgomery William W, the 5% owner of Applied DNA Sciences, Inc., bought 40,000 shares at the value of $5.25 during a trade that took place back on Jun 18, which means that Montgomery William W is holding 215,000 shares at the value of $210,000 based on the most recent closing price.

APDN Stock Fundamentals

The current profitability levels are settled at -169.31 for the present operating margin and +76.47 for gross margin. The net margin for Applied DNA Sciences, Inc. stands at -160.01. Total capital return value is set at -600.69, while invested capital returns managed to touch -566.39. Equity return holds the value -290.60%, with -120.10% for asset returns.

The value for Enterprise to Sales is 8.08 with debt to enterprise value settled at 0.17. The receivables turnover for Applied DNA Sciences, Inc. is 4.63 with the total asset turnover at the value of 1.17. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.96.

Related Articles

EOG Resources Inc. (EOG) Downgrade Issued by Wall Street Gurus

EOG Resources Inc. (NYSE:EOG) went down by -1.17% from its latest closing price compared to the recent 1-year high of $89.54. The company’s stock...

Why Nielsen Holdings plc (NLSN) Is in Such Horrid Condition

Nielsen Holdings plc (NYSE:NLSN) went down by -4.46% from its latest closing price compared to the recent 1-year high of $23.31. The company’s stock...

A Lesson to Learn: Kellogg Company (K)

Kellogg Company (NYSE:K) went down by -0.93% from its latest closing price compared to the recent 1-year high of $72.88. The company’s stock price...

Latest Posts

EOG Resources Inc. (EOG) Downgrade Issued by Wall Street Gurus

EOG Resources Inc. (NYSE:EOG) went down by -1.17% from its latest closing price compared to the recent 1-year high of $89.54. The company’s stock...

Why Nielsen Holdings plc (NLSN) Is in Such Horrid Condition

Nielsen Holdings plc (NYSE:NLSN) went down by -4.46% from its latest closing price compared to the recent 1-year high of $23.31. The company’s stock...

A Lesson to Learn: Kellogg Company (K)

Kellogg Company (NYSE:K) went down by -0.93% from its latest closing price compared to the recent 1-year high of $72.88. The company’s stock price...

Buy or Sell Ideanomics Inc. (IDEX) Stock Now | Don’t Try to Be a Top Gun

Ideanomics Inc. (NASDAQ:IDEX) went down by -2.88% from its latest closing price compared to the recent 1-year high of $3.98. The company’s stock price...

Amgen Inc. (AMGN) and the Battle of Fundamentals vs. Technicals

Amgen Inc. (NASDAQ:AMGN) went down by -0.15% from its latest closing price compared to the recent 1-year high of $264.97. The company’s stock price...